rss
Evid Based Med doi:10.1136/eb-2012-101188
  • Prevention
  • Randomised controlled trial

Modest cancer prevention benefit with long-term multivitamin supplementation: Physicians’ Health Study II results warrant cautious interpretation

  1. Wendy Demark-Wahnefried
  1. Department of Nutrition Sciences, University of Alabama, Birmingham, Alabama, USA
  1. Correspondence to : Wendy Demark-Wahnefried
    Department of Nutrition Sciences, University of Alabama, 1675 University Blvd rm. 346, Birmingham, AL 35294, USA; demark{at}uab.edu

Commentary on

Context

Various vitamins and minerals have been shown to inhibit carcinogenesis or reduce cancer risk in preclinical experiments and observational studies. Such work has given rise to several chemoprevention trials of isolated nutrients, many of which (eg, Alpha-Tocopherol and Beta-Carotene (ATBC) Trial, Carotene and Retinol Efficacy Trial (CARET) and Selenium and Vitamin E Cancer Prevention Trial (SELECT)) have produced disappointing findings.1 Multivitamin supplements, however, may yield greater benefit and less risk, since the nutrient profile more closely approximates a healthy, balanced diet. A randomised controlled trial (RCT) of multivitamin supplements is significant since over one-third of US adults regularly take these preparations.2

Methods

Gaziano and colleagues recently reported …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBM.
View free sample issue >>


Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article